{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:45:07Z","timestamp":1789731907702,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpba.2024.116489","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:26:53Z","timestamp":1727677613000},"page":"116489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["An LC MS\/MS method for the simultaneous determination of ten antimicrobials and its application in critically ill patients"],"prefix":"10.1016","volume":"252","author":[{"given":"Tingting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxuanzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116489_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106184","article-title":"Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections","volume":"56","author":"Bassetti","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2024.116489_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","article-title":"Timing of antibiotic therapy in the ICU","volume":"25","author":"Kollef","year":"2021","journal-title":"Crit. Care."},{"key":"10.1016\/j.jpba.2024.116489_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpba.2024.116489_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s13063-019-3911-5","article-title":"Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial","volume":"20","author":"Roggeveen","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jpba.2024.116489_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0034-1398490","article-title":"Applying pharmacokinetic\/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development","volume":"36","author":"Abdul-Aziz","year":"2015","journal-title":"Semin. Respir. Crit. Care. Med."},{"key":"10.1016\/j.jpba.2024.116489_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.11-1396","article-title":"Introduction to drug pharmacokinetics in the critically ill patient","volume":"141","author":"Smith","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jpba.2024.116489_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jpba.2024.116489_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-019-2438-1","article-title":"Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study","volume":"23","author":"Fleuren","year":"2019","journal-title":"Crit. Care."},{"key":"10.1016\/j.jpba.2024.116489_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care. Med."},{"key":"10.1016\/j.jpba.2024.116489_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-018-0880-z","article-title":"Therapeutic drug monitoring of beta-lactams and other antibiotics in the intensive care unit: which agents, which patients and which infections?","volume":"78","author":"Muller","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2024.116489_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/1120009X.2016.1157947","article-title":"Ultra high performance liquid chromatography-tandem mass spectrometry vs. commercial immunoassay for determination of vancomycin plasma concentration in children","volume":"28","author":"Barco","year":"2016","journal-title":"J. Chemother."},{"key":"10.1016\/j.jpba.2024.116489_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/phar.2279","article-title":"Falsely elevated vancomycin concentrations in a patient not receiving vancomycin","volume":"39","author":"Tsoi","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpba.2024.116489_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmsacl.2022.11.001","article-title":"LC-MS\/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring","volume":"26","author":"Radovanovic","year":"2022","journal-title":"J. Mass. Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jpba.2024.116489_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113273","article-title":"A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: application to critically ill pediatric patients","volume":"186","author":"Barco","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116489_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122160","article-title":"Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections","volume":"1157","author":"Decosterd","year":"2020","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.jpba.2024.116489_bib16","unstructured":"ICH M10, Draft Bioanalytical Method Validation (2019)."},{"key":"10.1016\/j.jpba.2024.116489_bib17","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00216-010-3986-z","article-title":"Therapeutic drug monitoring by LC-MS-MS with special focus on anti-infective drugs","volume":"398","author":"M\u00fcller","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116489_bib18","doi-asserted-by":"crossref","first-page":"1044234","DOI":"10.3389\/fphar.2022.1044234","article-title":"An LC-MS\/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116489_bib19","doi-asserted-by":"crossref","first-page":"1116071","DOI":"10.3389\/fphar.2023.1116071","article-title":"LC-MS\/MS-based multiplex antibacterial platform for therapeutic drug monitoring in intensive care unit patients","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116489_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2017.05.037","article-title":"Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV","volume":"143","author":"Pinder","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116489_bib21","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2014-0833","article-title":"Exploration of the pre-analytical stability of \u03b2-lactam antibiotics in plasma and blood-implications for therapeutic drug monitoring and pharmacokinetic studies","volume":"53","author":"Carlier","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2024.116489_bib22","article-title":"Quantification of cefepime, meropenem, piperacillin, and tazobactam in human plasma using a sensitive and robust liquid chromatography-tandem mass spectrometry method, part 1: assay development and validation","volume":"62","author":"Cunha","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2024.116489_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpba.2019.02.037","article-title":"LC-MS\/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples","volume":"169","author":"Ferrari","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116489_bib24","first-page":"188","article-title":"Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study","volume":"14","author":"Liu","year":"2024","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524005314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T19:26:41Z","timestamp":1730662001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524005314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S0731708524005314"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116489","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An LCMS\/MS method for the simultaneous determination of ten antimicrobials and its application in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116489"}}